Panuramine
From Wikipedia, the free encyclopedia
Clinical data | |
---|---|
ATC code |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C24H25N3O2 |
Molar mass | 387.483 g·mol−1 |
3D model (JSmol) | |
|
Panuramine (Wy-26,002) is an antidepressant which was synthesized in 1981 by Wyeth.[1] It acts as a potent and selective serotonin reuptake inhibitor (SSRI).[2] It was never marketed.[1]
See also[]
- Selective serotonin reuptake inhibitor
References[]
- ^ a b David J. Triggle (1997). Dictionary of pharmacological agents. London: Chapman & Hall. ISBN 0-412-46630-9.
- ^ Blurton PA, Broadhurst AM, Cross JA, Ennis C, Wood MD, Wyllie MG (September 1984). "Panuramine, a selective inhibitor of uptake of 5-hydroxytryptamine in the brain of the rat". Neuropharmacology. 23 (9): 1049–52. doi:10.1016/0028-3908(84)90127-8. PMID 6514142. S2CID 27269043.
Antidepressants (N06A) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| |||||||||||||||||||||
| |||||||||||||||||||||
| |||||||||||||||||||||
| |||||||||||||||||||||
| |||||||||||||||||||||
|
Monoamine reuptake inhibitors | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
DAT (DRIs) | |||||||||||||||
NET (NRIs) |
| ||||||||||||||
SERT (SRIs) |
| ||||||||||||||
VMATs |
| ||||||||||||||
Others |
| ||||||||||||||
See also: Receptor/signaling modulators • Monoamine releasing agents • Adrenergics • Dopaminergics • Serotonergics • Monoamine metabolism modulators • Monoamine neurotoxins |
Retrieved from ""
Categories:
- Drugs not assigned an ATC code
- Benzamides
- Naphthalenes
- Piperidines
- Selective serotonin reuptake inhibitors
- Ureas
Hidden categories:
- Articles without EBI source
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Drugs with no legal status
- Articles containing unverified chemical infoboxes